OTHERS PHARMANIAGA BERHAD ("PHARMANIAGA" OR "THE COMPANY") PROPOSED ACQUISITION OF 1,400,000 ORDINARY SHARES ("SALE SHARES") IN BIO-COLLAGEN TECHNOLOGIES SDN BHD ("BCTSB") REPRESENTING 70% OF THE TOTAL ISSUED AND PAID-UP SHARE CAPITAL ("PROPOSED ACQUISITION")

PHARMANIAGA BERHAD

Type Announcement
Subject OTHERS
Description 
PHARMANIAGA BERHAD ("PHARMANIAGA" OR "THE COMPANY") 

PROPOSED ACQUISITION OF 1,400,000 ORDINARY SHARES ("SALE SHARES") IN BIO-COLLAGEN TECHNOLOGIES SDN BHD ("BCTSB") REPRESENTING 70% OF THE TOTAL ISSUED AND PAID-UP SHARE CAPITAL ("PROPOSED ACQUISITION")

Reference is made to the announcement of Pharmaniaga Berhad ("Pharmaniaga" or "the Company") dated 28 August 2015 in relation to the Proposed Acquisition. Unless otherwise stated, the terms used herein shall have the same meaning as defined in the previous announcement.

The Board of Directors of Pharmaniaga Berhad wishes to announce that on 29 April 2016, the Company and the Vendor entered into the Supplemental Agreement (“Supplemental Agreement”) to vary and/or waive certain conditions precedent (“CP”) in the Share SPA, which the Board views will not be detrimental to the Company. The Supplemental Agreement is supplemental to and shall be read together with the Share SPA 

This announcement is dated 29 April 2016.


Please refer attachment below.


Announcement Info

Company Name PHARMANIAGA BERHAD
Stock Name PHARMA
Date Announced 29 Apr 2016
Category General Announcement for PLC
Reference Number GA1-26042016-00027